Pre-earnings options volume in Viking Therapeutics (VKTX) is 1.1x normal with calls leading puts 19:5. Implied volatility suggests the market is anticipating a move near 7.0%, or $2.21, after results are released. Median move over the past eight quarters is 6.4%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VKTX:
- VKTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Viking Therapeutics call volume above normal and directionally bullish
- 3 Best Stocks Under $50 to Buy in April 2026, According to Analysts
- Viking Therapeutics: Accelerated VK2735 Obesity Program and Single‑Molecule Strategy Support Buy Rating and Favorable Risk‑Reward
- Strong Enrollment and Phase 3 Momentum Underpin Buy Rating on Viking Therapeutics’ Obesity Program